SlideShare a Scribd company logo
Copyright © 2020 pubrica. All rights reserved 1
Pro Instrument and its Types
Dr. Nancy Agens, Head,
Technical Operations, Pubrica
sales@pubrica.com
I. INTRODUCTION
Patient-Reported Outcomes (PROs) is “ a
unique health status indicator that reveals
the current and past scenarios of a ones
health condition by the patient them self,
without any other interpretation (clinician
or care giver). “Patient-Reported
Outcome” (PRO) is considered a broad
phenomenon, encompassing various
factors of perceiving and quantifying a
person’s health status, which includes
health conditions (physical and mental),
health related quality of life (HRQOL),
social well being, clinical trials, functional
status linked with the treatment taken by
the patient etc. This self- appraisal system
is high essential to identify the best
practices of a health care that is qualified
to be a good outcome leading to a patient
centered health care system.
A PRO instrument is a rating scale that
critically evaluates the health outcomes,
satisfaction scores etc in a patients
viewpoint. PRO instruments are
considered as a primordial quality
indicator for health care service, which
gives valuable insights to the policy
makers, demand market and clinical
researchers. Literature has identified
several crucial factors for development of
a PRO instrument namely
1. Study parameters should hold strong
literature support
2. Should possess a conceptual structure
3. Should be drafted based on a end-point
model
4. Study must possess ideal number of
study items
5. The model should conceal identity of
the patients
6. Reproducible at any given point of
time
7. The questionnaire should be simplified
and understandable to the patients
Information’s retrieved by the PRO
instruments are instrumental in enhancing
the relationship between the patient,
his/her family and the doctors on the
whole. Further, the universal availability
of the content is expected to bring upon
striking changes in the policies by the
regulatory authorities, drug developers,
researchers, technologists and be used for
advanced clinical trials over the time.
II. PRO INSTRUMENTS AND ITS
TYPES
Any PRO instrument is developed
adopting four essential steps as approved
by US-FDA. This includes the a.
Hypothesis derivation and drafting of the
framework b. Identifying the
literature gaps and deleting or adding the
components based on it c. critical
content validation of the instrument;
defining of the scoring indices and d.
Final draft of the SOP, evaluation of the
patient response in different perspectives,
need for translation, changes for different
geographical locations will be executed.
Generally PRO instruments are developed
based on the need, intended purpose and
the target population. The commonly
known types of PRO instruments are
 Generic
 Disease specific
 Population specific
 Dimension specific
 Individualized
 Summary items
 Utility measures
Copyright © 2020 pubrica. All rights reserved 2
III. GENERIC PRO INSTRUMENT
Generic PRO instruments are used to
measure broad health aspects, illness
outcomes and are applicable for a wide
spectrum of patient groups and population
across the countries. The key benefits of
generic PRO instrument is that they are
ideally suitable to evaluate large number
of health disorders and can be used for
comparative studies among different
patient groups, treatment methods to
determine the competency of the models.
Additionally, generic PRO instrument
finds its applications in normative studies
on large population to assess the health
system, health interventions, to understand
the co-morbidities and to study the effect
of latest health care methodologies,
clinical trials etc. However, this instrument
is less sensitive as compared to other
models. Classic examples may include SF-
36, which studies the physical and mental
component of health in an 8-dimensional
scoring matrix, Psychological General
Well-Being Index (PGWBI)
IV. DISEASE SPECIFIC
This instrument aims to estimate the
patient's view of a specific disease or
disorder Specific instruments are made
developed targeting specific health
ailments. For example: Rheumatoid
Arthritis Quality of Life questionnaire
(RAQoL) developed to evaluate the patient
purview of health care and quality of life
with Rheumatoid Arthritis, The Asthma
Quality of Life Questionnaire contains 32
items yielding four dimension scores from
factors namely symptoms, activity
limitations, emotional function, and
environmental vulnerability.
V. POPULATION SPECIFIC
Population-specific instrument are
developed targeting a specific
demographic group (children or elderly
people) and geographic groups. The term
“Population specific” can be classified
based on disease condition, treatment
methods, population and geography. The
population specific PRO is a sensitive tool
is developed in precise manner to obtain
information’s in a narrowed window.
Example: The Child Health and Illness
Profile/CHIP developed for adolescents;
Cambridge Pulmonary Hypertension
Outcome Review (CAMPHOR)
VI. DIMENSION SPECIFIC
Dimension-specific instrument evaluates a
particular aspect of a person’s health. The
classic examples are physical function,
psychological wellness, personal strengths,
global health perspectives, specific role
based perceptions (house hold works, job,
finance), personal put up (appearance,
spiritual viewpoint, gratification). This
instrument is resourceful in providing
specific information as compared to the
generic or population specific PRO
instruments and they are highly competent.
It provides wide range of reliable data for
a better interpretation. The Beck
Depression Inventory contains 21 items
that effectively address symptoms of
depression.
VII. INDIVIDUALIZED PRO
INSTRUMENT
Individualized instruments enable patients
to frame their own choice of items and can
evaluate the significance of individual
items such as the health issue, other
concerns or factors that are not
predetermined by the evaluator. It
basically responds to the concerns of the
individual patient and not based on any
health standard. Therefore individualized
instruments are known to have higher
content validity. Classic example of this
PRO instrument is: The Patient Generated
Index where the respondents are asked to
list the five most important areas of their
Copyright © 2020 pubrica. All rights reserved 2
lives; Schedule for the Evaluation of
Individual Quality of Life (SEIQoL)
VIII. SUMMARY ITEMS
Summary item is a versatile PRO
instrument where respondents are asked to
consolidate the varied aspect of health
condition via a single item or a very small
number of items. It is less time consuming
and is used to get inputs from large sample
groups of a general population leading to
ample correlative evidences. However,
summary item restricts the specific
inferences that can be made on a specific
health disorder, which is due to its
conciseness. Example: Questions
(regarding limiting enduring illness) in
General Household Survey; the General
Household Survey for England and Wales
on chronic illness and disability.
IX. UTILITY MEASURES
Utility measures, involves choice or values
pertaining to an individual health condition
and represents it as a single index/score.
This PRO instrument evaluates the overall
strength of health status in a society and is
used for cost-utility analysis. It is
considered a generic type PRO however
uses specific numerical evaluation
methods to study health in a broad
spectrum. It is used to compare treatment
methods of different health problems and
its economic evaluation. Utility measures
are brief models and not applicable for
large number of states. Example: The
EuroQol EQ-5D contains five items
namely mobility, self-care, main activity,
pain/discomfort and anxiety/depression;
Utility measure for major, unipolar
depression (McSad)

More Related Content

What's hot

Population Management PCMH 2011 - Northwest Medical Partners
Population Management PCMH 2011 - Northwest Medical PartnersPopulation Management PCMH 2011 - Northwest Medical Partners
Population Management PCMH 2011 - Northwest Medical Partners
pedenton
 
Ethics in Clinical Trails- ICMR
Ethics in Clinical Trails- ICMREthics in Clinical Trails- ICMR
Ethics in Clinical Trails- ICMR
HarmanyPadsala
 
Medical audit process
Medical audit processMedical audit process
Medical audit process
sopi_1234
 
Passive and active surveillance
Passive and active surveillancePassive and active surveillance
Passive and active surveillance
Logesh kumar Selvaraj
 
Health Technology Assessments in India
Health Technology Assessments in IndiaHealth Technology Assessments in India
Health Technology Assessments in India
shashi sinha
 
14ab1 t0014 infection control committee and research & ethics committee
14ab1 t0014  infection control committee and research & ethics committee14ab1 t0014  infection control committee and research & ethics committee
14ab1 t0014 infection control committee and research & ethics committee
Ramesh Ganpisetti
 
Evidence based practice on patient safety
Evidence based practice on patient safetyEvidence based practice on patient safety
Evidence based practice on patient safety
Sawerigading Nursing Academy
 
Presentation on International Patient Safety Goals (JCI)
Presentation on International Patient Safety Goals (JCI)Presentation on International Patient Safety Goals (JCI)
Presentation on International Patient Safety Goals (JCI)
Dr.SONAL GAUR
 
Biostatistics Roles and Responsibilities in Clinical Research | Pubrica
Biostatistics Roles and Responsibilities in Clinical Research | PubricaBiostatistics Roles and Responsibilities in Clinical Research | Pubrica
Biostatistics Roles and Responsibilities in Clinical Research | Pubrica
Pubrica
 
Jci most common question
Jci most common questionJci most common question
Jci most common question
Joven Botin Bilbao
 
ECOGENE-21 translational research in genetics and omic sciences for applicati...
ECOGENE-21 translational research in genetics and omic sciences for applicati...ECOGENE-21 translational research in genetics and omic sciences for applicati...
ECOGENE-21 translational research in genetics and omic sciences for applicati...
Canadian Organization for Rare Disorders
 
INTERNATIONAL PATIENT SAFETY GOALS
INTERNATIONAL PATIENT SAFETY GOALSINTERNATIONAL PATIENT SAFETY GOALS
INTERNATIONAL PATIENT SAFETY GOALS
Joven Botin Bilbao
 
Health Technology Assessment- Overview
Health Technology Assessment- OverviewHealth Technology Assessment- Overview
Health Technology Assessment- Overview
shashi sinha
 
Guideline on patient safety and well being in clinical trials
Guideline on  patient safety and well being in clinical trialsGuideline on  patient safety and well being in clinical trials
Guideline on patient safety and well being in clinical trials
TrialJoin
 
Acc chapter presentation for JCI awarness week
Acc chapter presentation for JCI awarness weekAcc chapter presentation for JCI awarness week
Acc chapter presentation for JCI awarness weekDralaa Holiel , Ph.D
 
Pharmacovigilance and Materiovigilance, Drugs and Cosmetics Act
Pharmacovigilance and Materiovigilance, Drugs and Cosmetics ActPharmacovigilance and Materiovigilance, Drugs and Cosmetics Act
Pharmacovigilance and Materiovigilance, Drugs and Cosmetics Act
shashi sinha
 
The use of guidelines and clinical pathways
The use of guidelines and clinical pathwaysThe use of guidelines and clinical pathways
The use of guidelines and clinical pathways
Joven Botin Bilbao
 

What's hot (20)

Population Management PCMH 2011 - Northwest Medical Partners
Population Management PCMH 2011 - Northwest Medical PartnersPopulation Management PCMH 2011 - Northwest Medical Partners
Population Management PCMH 2011 - Northwest Medical Partners
 
Ethics in Clinical Trails- ICMR
Ethics in Clinical Trails- ICMREthics in Clinical Trails- ICMR
Ethics in Clinical Trails- ICMR
 
Medical audit process
Medical audit processMedical audit process
Medical audit process
 
Passive and active surveillance
Passive and active surveillancePassive and active surveillance
Passive and active surveillance
 
Health Technology Assessments in India
Health Technology Assessments in IndiaHealth Technology Assessments in India
Health Technology Assessments in India
 
Breast masses
Breast massesBreast masses
Breast masses
 
14ab1 t0014 infection control committee and research & ethics committee
14ab1 t0014  infection control committee and research & ethics committee14ab1 t0014  infection control committee and research & ethics committee
14ab1 t0014 infection control committee and research & ethics committee
 
Pharmaconomics
PharmaconomicsPharmaconomics
Pharmaconomics
 
Evidence based practice on patient safety
Evidence based practice on patient safetyEvidence based practice on patient safety
Evidence based practice on patient safety
 
Presentation on International Patient Safety Goals (JCI)
Presentation on International Patient Safety Goals (JCI)Presentation on International Patient Safety Goals (JCI)
Presentation on International Patient Safety Goals (JCI)
 
Biostatistics Roles and Responsibilities in Clinical Research | Pubrica
Biostatistics Roles and Responsibilities in Clinical Research | PubricaBiostatistics Roles and Responsibilities in Clinical Research | Pubrica
Biostatistics Roles and Responsibilities in Clinical Research | Pubrica
 
Jci most common question
Jci most common questionJci most common question
Jci most common question
 
ECOGENE-21 translational research in genetics and omic sciences for applicati...
ECOGENE-21 translational research in genetics and omic sciences for applicati...ECOGENE-21 translational research in genetics and omic sciences for applicati...
ECOGENE-21 translational research in genetics and omic sciences for applicati...
 
INTERNATIONAL PATIENT SAFETY GOALS
INTERNATIONAL PATIENT SAFETY GOALSINTERNATIONAL PATIENT SAFETY GOALS
INTERNATIONAL PATIENT SAFETY GOALS
 
Health Technology Assessment- Overview
Health Technology Assessment- OverviewHealth Technology Assessment- Overview
Health Technology Assessment- Overview
 
Guideline on patient safety and well being in clinical trials
Guideline on  patient safety and well being in clinical trialsGuideline on  patient safety and well being in clinical trials
Guideline on patient safety and well being in clinical trials
 
RW CV 22Sept15 4
RW CV 22Sept15 4RW CV 22Sept15 4
RW CV 22Sept15 4
 
Acc chapter presentation for JCI awarness week
Acc chapter presentation for JCI awarness weekAcc chapter presentation for JCI awarness week
Acc chapter presentation for JCI awarness week
 
Pharmacovigilance and Materiovigilance, Drugs and Cosmetics Act
Pharmacovigilance and Materiovigilance, Drugs and Cosmetics ActPharmacovigilance and Materiovigilance, Drugs and Cosmetics Act
Pharmacovigilance and Materiovigilance, Drugs and Cosmetics Act
 
The use of guidelines and clinical pathways
The use of guidelines and clinical pathwaysThe use of guidelines and clinical pathways
The use of guidelines and clinical pathways
 

Similar to Pro instrument and its types - pubrica

Xx..health related quality of lif e
Xx..health related quality of lif eXx..health related quality of lif e
Xx..health related quality of lif e
Yelmi Reni Putri SY
 
Integration of HEOR into Global Publication Plans
Integration of HEOR into Global Publication PlansIntegration of HEOR into Global Publication Plans
Integration of HEOR into Global Publication Plans
Dr. Kavita Lamror
 
International Journal for Quality in Health Care 2003; Volume .docx
International Journal for Quality in Health Care 2003; Volume .docxInternational Journal for Quality in Health Care 2003; Volume .docx
International Journal for Quality in Health Care 2003; Volume .docx
normanibarber20063
 
Applications of statistics in medical Research and Healthr
Applications of statistics in medical Research and HealthrApplications of statistics in medical Research and Healthr
Applications of statistics in medical Research and Healthr
MuhammadNafees42
 
It is time to make a move new
It is time to make a move newIt is time to make a move new
It is time to make a move newAcri India
 
The Role of Real World Evidence in Clinical Research and Regulatory Decision ...
The Role of Real World Evidence in Clinical Research and Regulatory Decision ...The Role of Real World Evidence in Clinical Research and Regulatory Decision ...
The Role of Real World Evidence in Clinical Research and Regulatory Decision ...
ijtsrd
 
CLINICAL TRIAL PROTOCOL
CLINICAL TRIAL PROTOCOLCLINICAL TRIAL PROTOCOL
CLINICAL TRIAL PROTOCOL
Jayvantika Raulji
 
Workshop 3 - "Feedback from the 15 National Conferences on Registries"
Workshop 3 - "Feedback from the 15 National Conferences on Registries" Workshop 3 - "Feedback from the 15 National Conferences on Registries"
Workshop 3 - "Feedback from the 15 National Conferences on Registries"
EURORDIS - Rare Diseases Europe
 
Patient's length of stay data.
Patient's length of stay data.Patient's length of stay data.
Patient's length of stay data.
assignmentcafe1
 
Clinical research
Clinical researchClinical research
Clinical research
DABBETA DIVYA
 
DHP Research Patient Reported Outcome (PRO) Measures Workshop
DHP Research Patient Reported Outcome (PRO) Measures WorkshopDHP Research Patient Reported Outcome (PRO) Measures Workshop
DHP Research Patient Reported Outcome (PRO) Measures Workshop
Keith Meadows
 
White paper 5 things you need to know about patient reported outcome (pro) ...
White paper   5 things you need to know about patient reported outcome (pro) ...White paper   5 things you need to know about patient reported outcome (pro) ...
White paper 5 things you need to know about patient reported outcome (pro) ...
Keith Meadows
 
Clinical trail protocol and development
Clinical trail protocol and developmentClinical trail protocol and development
Clinical trail protocol and development
ChintamBaladattaSai
 
Designing clinical trials on lifestyle interventions using patient reported o...
Designing clinical trials on lifestyle interventions using patient reported o...Designing clinical trials on lifestyle interventions using patient reported o...
Designing clinical trials on lifestyle interventions using patient reported o...
Jim Roldan
 
Four strategies to upgrade clinical trial quality in this computerized world ...
Four strategies to upgrade clinical trial quality in this computerized world ...Four strategies to upgrade clinical trial quality in this computerized world ...
Four strategies to upgrade clinical trial quality in this computerized world ...
Pubrica
 
20150300.0 00014
20150300.0 0001420150300.0 00014
20150300.0 00014
samirsharshar
 
What is The Clinical Trial Approval Process In India.pdf
What is The Clinical Trial Approval Process In India.pdfWhat is The Clinical Trial Approval Process In India.pdf
What is The Clinical Trial Approval Process In India.pdf
PranshuCorpseed
 

Similar to Pro instrument and its types - pubrica (20)

Xx..health related quality of lif e
Xx..health related quality of lif eXx..health related quality of lif e
Xx..health related quality of lif e
 
Integration of HEOR into Global Publication Plans
Integration of HEOR into Global Publication PlansIntegration of HEOR into Global Publication Plans
Integration of HEOR into Global Publication Plans
 
International Journal for Quality in Health Care 2003; Volume .docx
International Journal for Quality in Health Care 2003; Volume .docxInternational Journal for Quality in Health Care 2003; Volume .docx
International Journal for Quality in Health Care 2003; Volume .docx
 
Applications of statistics in medical Research and Healthr
Applications of statistics in medical Research and HealthrApplications of statistics in medical Research and Healthr
Applications of statistics in medical Research and Healthr
 
It is time to make a move new
It is time to make a move newIt is time to make a move new
It is time to make a move new
 
The Role of Real World Evidence in Clinical Research and Regulatory Decision ...
The Role of Real World Evidence in Clinical Research and Regulatory Decision ...The Role of Real World Evidence in Clinical Research and Regulatory Decision ...
The Role of Real World Evidence in Clinical Research and Regulatory Decision ...
 
Hrqol neuro
Hrqol neuroHrqol neuro
Hrqol neuro
 
Health qual life outcomes
Health qual life outcomesHealth qual life outcomes
Health qual life outcomes
 
CLINICAL TRIAL PROTOCOL
CLINICAL TRIAL PROTOCOLCLINICAL TRIAL PROTOCOL
CLINICAL TRIAL PROTOCOL
 
Workshop 3 - "Feedback from the 15 National Conferences on Registries"
Workshop 3 - "Feedback from the 15 National Conferences on Registries" Workshop 3 - "Feedback from the 15 National Conferences on Registries"
Workshop 3 - "Feedback from the 15 National Conferences on Registries"
 
Patient's length of stay data.
Patient's length of stay data.Patient's length of stay data.
Patient's length of stay data.
 
Clinical research
Clinical researchClinical research
Clinical research
 
DHP Research Patient Reported Outcome (PRO) Measures Workshop
DHP Research Patient Reported Outcome (PRO) Measures WorkshopDHP Research Patient Reported Outcome (PRO) Measures Workshop
DHP Research Patient Reported Outcome (PRO) Measures Workshop
 
Towards a learning health system
Towards a learning health systemTowards a learning health system
Towards a learning health system
 
White paper 5 things you need to know about patient reported outcome (pro) ...
White paper   5 things you need to know about patient reported outcome (pro) ...White paper   5 things you need to know about patient reported outcome (pro) ...
White paper 5 things you need to know about patient reported outcome (pro) ...
 
Clinical trail protocol and development
Clinical trail protocol and developmentClinical trail protocol and development
Clinical trail protocol and development
 
Designing clinical trials on lifestyle interventions using patient reported o...
Designing clinical trials on lifestyle interventions using patient reported o...Designing clinical trials on lifestyle interventions using patient reported o...
Designing clinical trials on lifestyle interventions using patient reported o...
 
Four strategies to upgrade clinical trial quality in this computerized world ...
Four strategies to upgrade clinical trial quality in this computerized world ...Four strategies to upgrade clinical trial quality in this computerized world ...
Four strategies to upgrade clinical trial quality in this computerized world ...
 
20150300.0 00014
20150300.0 0001420150300.0 00014
20150300.0 00014
 
What is The Clinical Trial Approval Process In India.pdf
What is The Clinical Trial Approval Process In India.pdfWhat is The Clinical Trial Approval Process In India.pdf
What is The Clinical Trial Approval Process In India.pdf
 

More from Pubrica

What are the differences in publishing diabetes epidemiological manuscripts.pdf
What are the differences in publishing diabetes epidemiological manuscripts.pdfWhat are the differences in publishing diabetes epidemiological manuscripts.pdf
What are the differences in publishing diabetes epidemiological manuscripts.pdf
Pubrica
 
Case-control studies epidemiology | Clinical epidemiology and biostatistics |...
Case-control studies epidemiology | Clinical epidemiology and biostatistics |...Case-control studies epidemiology | Clinical epidemiology and biostatistics |...
Case-control studies epidemiology | Clinical epidemiology and biostatistics |...
Pubrica
 
Epidemiological studies that can be conducted in respiratory research?
 Epidemiological studies that can be conducted in respiratory research? Epidemiological studies that can be conducted in respiratory research?
Epidemiological studies that can be conducted in respiratory research?
Pubrica
 
Medical case series | Writing services the clinical case report for Scientif...
 Medical case series | Writing services the clinical case report for Scientif... Medical case series | Writing services the clinical case report for Scientif...
Medical case series | Writing services the clinical case report for Scientif...
Pubrica
 
Clinical Cohort Studies | Peer review process | Scientific publication
Clinical Cohort Studies | Peer review process | Scientific publicationClinical Cohort Studies | Peer review process | Scientific publication
Clinical Cohort Studies | Peer review process | Scientific publication
Pubrica
 
Research and Scientific Journal Publication support services | Research pape...
 Research and Scientific Journal Publication support services | Research pape... Research and Scientific Journal Publication support services | Research pape...
Research and Scientific Journal Publication support services | Research pape...
Pubrica
 
How Randomized Controlled Trials are Used in Meta-Analysis
How Randomized Controlled Trials are Used in Meta-Analysis How Randomized Controlled Trials are Used in Meta-Analysis
How Randomized Controlled Trials are Used in Meta-Analysis
Pubrica
 
Statistical analyses services | Pharmaceutical writing companies | Statistica...
Statistical analyses services | Pharmaceutical writing companies | Statistica...Statistical analyses services | Pharmaceutical writing companies | Statistica...
Statistical analyses services | Pharmaceutical writing companies | Statistica...
Pubrica
 
Systematic literature review services | Cardiovascular research | Bariatric s...
Systematic literature review services | Cardiovascular research | Bariatric s...Systematic literature review services | Cardiovascular research | Bariatric s...
Systematic literature review services | Cardiovascular research | Bariatric s...
Pubrica
 
Electronic health records | Data collection systems | Data collection and ana...
Electronic health records | Data collection systems | Data collection and ana...Electronic health records | Data collection systems | Data collection and ana...
Electronic health records | Data collection systems | Data collection and ana...
Pubrica
 
Assessing Evidence-Based Practice in Physical Therapy: A Multifaceted Mixed-M...
Assessing Evidence-Based Practice in Physical Therapy: A Multifaceted Mixed-M...Assessing Evidence-Based Practice in Physical Therapy: A Multifaceted Mixed-M...
Assessing Evidence-Based Practice in Physical Therapy: A Multifaceted Mixed-M...
Pubrica
 
A comprehensive study of clinical efficacy in cochlear implant surgery among ...
A comprehensive study of clinical efficacy in cochlear implant surgery among ...A comprehensive study of clinical efficacy in cochlear implant surgery among ...
A comprehensive study of clinical efficacy in cochlear implant surgery among ...
Pubrica
 
Cytotoxic | Primary research | Silver nanoparticles
Cytotoxic | Primary research | Silver nanoparticlesCytotoxic | Primary research | Silver nanoparticles
Cytotoxic | Primary research | Silver nanoparticles
Pubrica
 
Journal article | Original research article | Qualitative and quantitative re...
Journal article | Original research article | Qualitative and quantitative re...Journal article | Original research article | Qualitative and quantitative re...
Journal article | Original research article | Qualitative and quantitative re...
Pubrica
 
What are the suggestions given by peer reviewers in the introduction section ...
What are the suggestions given by peer reviewers in the introduction section ...What are the suggestions given by peer reviewers in the introduction section ...
What are the suggestions given by peer reviewers in the introduction section ...
Pubrica
 
Addressing to Reviewers’ Comments.pdf
Addressing to Reviewers’ Comments.pdfAddressing to Reviewers’ Comments.pdf
Addressing to Reviewers’ Comments.pdf
Pubrica
 
Manuscript review guidelines | Manuscript peer reviewer | Address Reviewer Co...
Manuscript review guidelines | Manuscript peer reviewer | Address Reviewer Co...Manuscript review guidelines | Manuscript peer reviewer | Address Reviewer Co...
Manuscript review guidelines | Manuscript peer reviewer | Address Reviewer Co...
Pubrica
 
Experimental research design | Descriptive quantitative research | Data colle...
Experimental research design | Descriptive quantitative research | Data colle...Experimental research design | Descriptive quantitative research | Data colle...
Experimental research design | Descriptive quantitative research | Data colle...
Pubrica
 
Data gathering | Primary data collection | Healthcare blockchain
Data gathering | Primary data collection | Healthcare blockchainData gathering | Primary data collection | Healthcare blockchain
Data gathering | Primary data collection | Healthcare blockchain
Pubrica
 
Narrative review | Systematic review | Data extraction
Narrative review | Systematic review | Data extractionNarrative review | Systematic review | Data extraction
Narrative review | Systematic review | Data extraction
Pubrica
 

More from Pubrica (20)

What are the differences in publishing diabetes epidemiological manuscripts.pdf
What are the differences in publishing diabetes epidemiological manuscripts.pdfWhat are the differences in publishing diabetes epidemiological manuscripts.pdf
What are the differences in publishing diabetes epidemiological manuscripts.pdf
 
Case-control studies epidemiology | Clinical epidemiology and biostatistics |...
Case-control studies epidemiology | Clinical epidemiology and biostatistics |...Case-control studies epidemiology | Clinical epidemiology and biostatistics |...
Case-control studies epidemiology | Clinical epidemiology and biostatistics |...
 
Epidemiological studies that can be conducted in respiratory research?
 Epidemiological studies that can be conducted in respiratory research? Epidemiological studies that can be conducted in respiratory research?
Epidemiological studies that can be conducted in respiratory research?
 
Medical case series | Writing services the clinical case report for Scientif...
 Medical case series | Writing services the clinical case report for Scientif... Medical case series | Writing services the clinical case report for Scientif...
Medical case series | Writing services the clinical case report for Scientif...
 
Clinical Cohort Studies | Peer review process | Scientific publication
Clinical Cohort Studies | Peer review process | Scientific publicationClinical Cohort Studies | Peer review process | Scientific publication
Clinical Cohort Studies | Peer review process | Scientific publication
 
Research and Scientific Journal Publication support services | Research pape...
 Research and Scientific Journal Publication support services | Research pape... Research and Scientific Journal Publication support services | Research pape...
Research and Scientific Journal Publication support services | Research pape...
 
How Randomized Controlled Trials are Used in Meta-Analysis
How Randomized Controlled Trials are Used in Meta-Analysis How Randomized Controlled Trials are Used in Meta-Analysis
How Randomized Controlled Trials are Used in Meta-Analysis
 
Statistical analyses services | Pharmaceutical writing companies | Statistica...
Statistical analyses services | Pharmaceutical writing companies | Statistica...Statistical analyses services | Pharmaceutical writing companies | Statistica...
Statistical analyses services | Pharmaceutical writing companies | Statistica...
 
Systematic literature review services | Cardiovascular research | Bariatric s...
Systematic literature review services | Cardiovascular research | Bariatric s...Systematic literature review services | Cardiovascular research | Bariatric s...
Systematic literature review services | Cardiovascular research | Bariatric s...
 
Electronic health records | Data collection systems | Data collection and ana...
Electronic health records | Data collection systems | Data collection and ana...Electronic health records | Data collection systems | Data collection and ana...
Electronic health records | Data collection systems | Data collection and ana...
 
Assessing Evidence-Based Practice in Physical Therapy: A Multifaceted Mixed-M...
Assessing Evidence-Based Practice in Physical Therapy: A Multifaceted Mixed-M...Assessing Evidence-Based Practice in Physical Therapy: A Multifaceted Mixed-M...
Assessing Evidence-Based Practice in Physical Therapy: A Multifaceted Mixed-M...
 
A comprehensive study of clinical efficacy in cochlear implant surgery among ...
A comprehensive study of clinical efficacy in cochlear implant surgery among ...A comprehensive study of clinical efficacy in cochlear implant surgery among ...
A comprehensive study of clinical efficacy in cochlear implant surgery among ...
 
Cytotoxic | Primary research | Silver nanoparticles
Cytotoxic | Primary research | Silver nanoparticlesCytotoxic | Primary research | Silver nanoparticles
Cytotoxic | Primary research | Silver nanoparticles
 
Journal article | Original research article | Qualitative and quantitative re...
Journal article | Original research article | Qualitative and quantitative re...Journal article | Original research article | Qualitative and quantitative re...
Journal article | Original research article | Qualitative and quantitative re...
 
What are the suggestions given by peer reviewers in the introduction section ...
What are the suggestions given by peer reviewers in the introduction section ...What are the suggestions given by peer reviewers in the introduction section ...
What are the suggestions given by peer reviewers in the introduction section ...
 
Addressing to Reviewers’ Comments.pdf
Addressing to Reviewers’ Comments.pdfAddressing to Reviewers’ Comments.pdf
Addressing to Reviewers’ Comments.pdf
 
Manuscript review guidelines | Manuscript peer reviewer | Address Reviewer Co...
Manuscript review guidelines | Manuscript peer reviewer | Address Reviewer Co...Manuscript review guidelines | Manuscript peer reviewer | Address Reviewer Co...
Manuscript review guidelines | Manuscript peer reviewer | Address Reviewer Co...
 
Experimental research design | Descriptive quantitative research | Data colle...
Experimental research design | Descriptive quantitative research | Data colle...Experimental research design | Descriptive quantitative research | Data colle...
Experimental research design | Descriptive quantitative research | Data colle...
 
Data gathering | Primary data collection | Healthcare blockchain
Data gathering | Primary data collection | Healthcare blockchainData gathering | Primary data collection | Healthcare blockchain
Data gathering | Primary data collection | Healthcare blockchain
 
Narrative review | Systematic review | Data extraction
Narrative review | Systematic review | Data extractionNarrative review | Systematic review | Data extraction
Narrative review | Systematic review | Data extraction
 

Recently uploaded

How to Build a Module in Odoo 17 Using the Scaffold Method
How to Build a Module in Odoo 17 Using the Scaffold MethodHow to Build a Module in Odoo 17 Using the Scaffold Method
How to Build a Module in Odoo 17 Using the Scaffold Method
Celine George
 
Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.
Ashokrao Mane college of Pharmacy Peth-Vadgaon
 
Natural birth techniques - Mrs.Akanksha Trivedi Rama University
Natural birth techniques - Mrs.Akanksha Trivedi Rama UniversityNatural birth techniques - Mrs.Akanksha Trivedi Rama University
Natural birth techniques - Mrs.Akanksha Trivedi Rama University
Akanksha trivedi rama nursing college kanpur.
 
What is the purpose of studying mathematics.pptx
What is the purpose of studying mathematics.pptxWhat is the purpose of studying mathematics.pptx
What is the purpose of studying mathematics.pptx
christianmathematics
 
MASS MEDIA STUDIES-835-CLASS XI Resource Material.pdf
MASS MEDIA STUDIES-835-CLASS XI Resource Material.pdfMASS MEDIA STUDIES-835-CLASS XI Resource Material.pdf
MASS MEDIA STUDIES-835-CLASS XI Resource Material.pdf
goswamiyash170123
 
PIMS Job Advertisement 2024.pdf Islamabad
PIMS Job Advertisement 2024.pdf IslamabadPIMS Job Advertisement 2024.pdf Islamabad
PIMS Job Advertisement 2024.pdf Islamabad
AyyanKhan40
 
Best Digital Marketing Institute In NOIDA
Best Digital Marketing Institute In NOIDABest Digital Marketing Institute In NOIDA
Best Digital Marketing Institute In NOIDA
deeptiverma2406
 
Fresher’s Quiz 2023 at GMC Nizamabad.pptx
Fresher’s Quiz 2023 at GMC Nizamabad.pptxFresher’s Quiz 2023 at GMC Nizamabad.pptx
Fresher’s Quiz 2023 at GMC Nizamabad.pptx
SriSurya50
 
DRUGS AND ITS classification slide share
DRUGS AND ITS classification slide shareDRUGS AND ITS classification slide share
DRUGS AND ITS classification slide share
taiba qazi
 
S1-Introduction-Biopesticides in ICM.pptx
S1-Introduction-Biopesticides in ICM.pptxS1-Introduction-Biopesticides in ICM.pptx
S1-Introduction-Biopesticides in ICM.pptx
tarandeep35
 
Reflective and Evaluative Practice...pdf
Reflective and Evaluative Practice...pdfReflective and Evaluative Practice...pdf
Reflective and Evaluative Practice...pdf
amberjdewit93
 
Aficamten in HCM (SEQUOIA HCM TRIAL 2024)
Aficamten in HCM (SEQUOIA HCM TRIAL 2024)Aficamten in HCM (SEQUOIA HCM TRIAL 2024)
Aficamten in HCM (SEQUOIA HCM TRIAL 2024)
Ashish Kohli
 
Advantages and Disadvantages of CMS from an SEO Perspective
Advantages and Disadvantages of CMS from an SEO PerspectiveAdvantages and Disadvantages of CMS from an SEO Perspective
Advantages and Disadvantages of CMS from an SEO Perspective
Krisztián Száraz
 
CACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdfCACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdf
camakaiclarkmusic
 
Thesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.pptThesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.ppt
EverAndrsGuerraGuerr
 
The basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptxThe basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptx
heathfieldcps1
 
clinical examination of hip joint (1).pdf
clinical examination of hip joint (1).pdfclinical examination of hip joint (1).pdf
clinical examination of hip joint (1).pdf
Priyankaranawat4
 
Digital Artifact 1 - 10VCD Environments Unit
Digital Artifact 1 - 10VCD Environments UnitDigital Artifact 1 - 10VCD Environments Unit
Digital Artifact 1 - 10VCD Environments Unit
chanes7
 
Reflective and Evaluative Practice PowerPoint
Reflective and Evaluative Practice PowerPointReflective and Evaluative Practice PowerPoint
Reflective and Evaluative Practice PowerPoint
amberjdewit93
 
The simplified electron and muon model, Oscillating Spacetime: The Foundation...
The simplified electron and muon model, Oscillating Spacetime: The Foundation...The simplified electron and muon model, Oscillating Spacetime: The Foundation...
The simplified electron and muon model, Oscillating Spacetime: The Foundation...
RitikBhardwaj56
 

Recently uploaded (20)

How to Build a Module in Odoo 17 Using the Scaffold Method
How to Build a Module in Odoo 17 Using the Scaffold MethodHow to Build a Module in Odoo 17 Using the Scaffold Method
How to Build a Module in Odoo 17 Using the Scaffold Method
 
Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.
 
Natural birth techniques - Mrs.Akanksha Trivedi Rama University
Natural birth techniques - Mrs.Akanksha Trivedi Rama UniversityNatural birth techniques - Mrs.Akanksha Trivedi Rama University
Natural birth techniques - Mrs.Akanksha Trivedi Rama University
 
What is the purpose of studying mathematics.pptx
What is the purpose of studying mathematics.pptxWhat is the purpose of studying mathematics.pptx
What is the purpose of studying mathematics.pptx
 
MASS MEDIA STUDIES-835-CLASS XI Resource Material.pdf
MASS MEDIA STUDIES-835-CLASS XI Resource Material.pdfMASS MEDIA STUDIES-835-CLASS XI Resource Material.pdf
MASS MEDIA STUDIES-835-CLASS XI Resource Material.pdf
 
PIMS Job Advertisement 2024.pdf Islamabad
PIMS Job Advertisement 2024.pdf IslamabadPIMS Job Advertisement 2024.pdf Islamabad
PIMS Job Advertisement 2024.pdf Islamabad
 
Best Digital Marketing Institute In NOIDA
Best Digital Marketing Institute In NOIDABest Digital Marketing Institute In NOIDA
Best Digital Marketing Institute In NOIDA
 
Fresher’s Quiz 2023 at GMC Nizamabad.pptx
Fresher’s Quiz 2023 at GMC Nizamabad.pptxFresher’s Quiz 2023 at GMC Nizamabad.pptx
Fresher’s Quiz 2023 at GMC Nizamabad.pptx
 
DRUGS AND ITS classification slide share
DRUGS AND ITS classification slide shareDRUGS AND ITS classification slide share
DRUGS AND ITS classification slide share
 
S1-Introduction-Biopesticides in ICM.pptx
S1-Introduction-Biopesticides in ICM.pptxS1-Introduction-Biopesticides in ICM.pptx
S1-Introduction-Biopesticides in ICM.pptx
 
Reflective and Evaluative Practice...pdf
Reflective and Evaluative Practice...pdfReflective and Evaluative Practice...pdf
Reflective and Evaluative Practice...pdf
 
Aficamten in HCM (SEQUOIA HCM TRIAL 2024)
Aficamten in HCM (SEQUOIA HCM TRIAL 2024)Aficamten in HCM (SEQUOIA HCM TRIAL 2024)
Aficamten in HCM (SEQUOIA HCM TRIAL 2024)
 
Advantages and Disadvantages of CMS from an SEO Perspective
Advantages and Disadvantages of CMS from an SEO PerspectiveAdvantages and Disadvantages of CMS from an SEO Perspective
Advantages and Disadvantages of CMS from an SEO Perspective
 
CACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdfCACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdf
 
Thesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.pptThesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.ppt
 
The basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptxThe basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptx
 
clinical examination of hip joint (1).pdf
clinical examination of hip joint (1).pdfclinical examination of hip joint (1).pdf
clinical examination of hip joint (1).pdf
 
Digital Artifact 1 - 10VCD Environments Unit
Digital Artifact 1 - 10VCD Environments UnitDigital Artifact 1 - 10VCD Environments Unit
Digital Artifact 1 - 10VCD Environments Unit
 
Reflective and Evaluative Practice PowerPoint
Reflective and Evaluative Practice PowerPointReflective and Evaluative Practice PowerPoint
Reflective and Evaluative Practice PowerPoint
 
The simplified electron and muon model, Oscillating Spacetime: The Foundation...
The simplified electron and muon model, Oscillating Spacetime: The Foundation...The simplified electron and muon model, Oscillating Spacetime: The Foundation...
The simplified electron and muon model, Oscillating Spacetime: The Foundation...
 

Pro instrument and its types - pubrica

  • 1. Copyright © 2020 pubrica. All rights reserved 1 Pro Instrument and its Types Dr. Nancy Agens, Head, Technical Operations, Pubrica sales@pubrica.com I. INTRODUCTION Patient-Reported Outcomes (PROs) is “ a unique health status indicator that reveals the current and past scenarios of a ones health condition by the patient them self, without any other interpretation (clinician or care giver). “Patient-Reported Outcome” (PRO) is considered a broad phenomenon, encompassing various factors of perceiving and quantifying a person’s health status, which includes health conditions (physical and mental), health related quality of life (HRQOL), social well being, clinical trials, functional status linked with the treatment taken by the patient etc. This self- appraisal system is high essential to identify the best practices of a health care that is qualified to be a good outcome leading to a patient centered health care system. A PRO instrument is a rating scale that critically evaluates the health outcomes, satisfaction scores etc in a patients viewpoint. PRO instruments are considered as a primordial quality indicator for health care service, which gives valuable insights to the policy makers, demand market and clinical researchers. Literature has identified several crucial factors for development of a PRO instrument namely 1. Study parameters should hold strong literature support 2. Should possess a conceptual structure 3. Should be drafted based on a end-point model 4. Study must possess ideal number of study items 5. The model should conceal identity of the patients 6. Reproducible at any given point of time 7. The questionnaire should be simplified and understandable to the patients Information’s retrieved by the PRO instruments are instrumental in enhancing the relationship between the patient, his/her family and the doctors on the whole. Further, the universal availability of the content is expected to bring upon striking changes in the policies by the regulatory authorities, drug developers, researchers, technologists and be used for advanced clinical trials over the time. II. PRO INSTRUMENTS AND ITS TYPES Any PRO instrument is developed adopting four essential steps as approved by US-FDA. This includes the a. Hypothesis derivation and drafting of the framework b. Identifying the literature gaps and deleting or adding the components based on it c. critical content validation of the instrument; defining of the scoring indices and d. Final draft of the SOP, evaluation of the patient response in different perspectives, need for translation, changes for different geographical locations will be executed. Generally PRO instruments are developed based on the need, intended purpose and the target population. The commonly known types of PRO instruments are  Generic  Disease specific  Population specific  Dimension specific  Individualized  Summary items  Utility measures
  • 2. Copyright © 2020 pubrica. All rights reserved 2 III. GENERIC PRO INSTRUMENT Generic PRO instruments are used to measure broad health aspects, illness outcomes and are applicable for a wide spectrum of patient groups and population across the countries. The key benefits of generic PRO instrument is that they are ideally suitable to evaluate large number of health disorders and can be used for comparative studies among different patient groups, treatment methods to determine the competency of the models. Additionally, generic PRO instrument finds its applications in normative studies on large population to assess the health system, health interventions, to understand the co-morbidities and to study the effect of latest health care methodologies, clinical trials etc. However, this instrument is less sensitive as compared to other models. Classic examples may include SF- 36, which studies the physical and mental component of health in an 8-dimensional scoring matrix, Psychological General Well-Being Index (PGWBI) IV. DISEASE SPECIFIC This instrument aims to estimate the patient's view of a specific disease or disorder Specific instruments are made developed targeting specific health ailments. For example: Rheumatoid Arthritis Quality of Life questionnaire (RAQoL) developed to evaluate the patient purview of health care and quality of life with Rheumatoid Arthritis, The Asthma Quality of Life Questionnaire contains 32 items yielding four dimension scores from factors namely symptoms, activity limitations, emotional function, and environmental vulnerability. V. POPULATION SPECIFIC Population-specific instrument are developed targeting a specific demographic group (children or elderly people) and geographic groups. The term “Population specific” can be classified based on disease condition, treatment methods, population and geography. The population specific PRO is a sensitive tool is developed in precise manner to obtain information’s in a narrowed window. Example: The Child Health and Illness Profile/CHIP developed for adolescents; Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) VI. DIMENSION SPECIFIC Dimension-specific instrument evaluates a particular aspect of a person’s health. The classic examples are physical function, psychological wellness, personal strengths, global health perspectives, specific role based perceptions (house hold works, job, finance), personal put up (appearance, spiritual viewpoint, gratification). This instrument is resourceful in providing specific information as compared to the generic or population specific PRO instruments and they are highly competent. It provides wide range of reliable data for a better interpretation. The Beck Depression Inventory contains 21 items that effectively address symptoms of depression. VII. INDIVIDUALIZED PRO INSTRUMENT Individualized instruments enable patients to frame their own choice of items and can evaluate the significance of individual items such as the health issue, other concerns or factors that are not predetermined by the evaluator. It basically responds to the concerns of the individual patient and not based on any health standard. Therefore individualized instruments are known to have higher content validity. Classic example of this PRO instrument is: The Patient Generated Index where the respondents are asked to list the five most important areas of their
  • 3. Copyright © 2020 pubrica. All rights reserved 2 lives; Schedule for the Evaluation of Individual Quality of Life (SEIQoL) VIII. SUMMARY ITEMS Summary item is a versatile PRO instrument where respondents are asked to consolidate the varied aspect of health condition via a single item or a very small number of items. It is less time consuming and is used to get inputs from large sample groups of a general population leading to ample correlative evidences. However, summary item restricts the specific inferences that can be made on a specific health disorder, which is due to its conciseness. Example: Questions (regarding limiting enduring illness) in General Household Survey; the General Household Survey for England and Wales on chronic illness and disability. IX. UTILITY MEASURES Utility measures, involves choice or values pertaining to an individual health condition and represents it as a single index/score. This PRO instrument evaluates the overall strength of health status in a society and is used for cost-utility analysis. It is considered a generic type PRO however uses specific numerical evaluation methods to study health in a broad spectrum. It is used to compare treatment methods of different health problems and its economic evaluation. Utility measures are brief models and not applicable for large number of states. Example: The EuroQol EQ-5D contains five items namely mobility, self-care, main activity, pain/discomfort and anxiety/depression; Utility measure for major, unipolar depression (McSad)